Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages 342-347

  Hadaegh, Farzad ^a   Shafiee, Gita ^a   Ghasemi, Asghar ^b   Sarbakhsh, Parvin ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Diabetes mellitus; Metabolic syndrome

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREDIABETIC STATE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77649185395     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.11.010     Document Type: Article

References (19)

1. Harati H., Hadaegh F., Saadat N., and Azizi F. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 9 (2009) 186
2. Hossain P., Kawar B., and El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 356 (2007) 213-215
3. Hadaegh F., Khalili D., Fahimfar N., Tohidi M., Eskandari F., and Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J. Endocrinol. Invest. (2009) [in press]
4. Preiss D., and Sattar N. Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart 93 (2007) 1493-1496
5. Reaven G.M., and Chen Y.D. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab. Rev. 4 (1988) 639-652
6. Zabetian A., Hadaegh F., and Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp. Clin. Endocrinol. Diabetes (2008)
7. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007) 403-414
8. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
9. Liu J., Grundy S.M., Wang W., Smith Jr. S.C., Vega G.L., Wu Z., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am. Heart J. 153 (2007) 552-558
10. Church T.S., Thompson A.M., Katzmarzyk P.T., Sui X., Johannsen N., Earnest C.P., et al. Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men. Diabetes Care 32 (2009) 1289-1294
11. Hadaegh F., Bozorgmanesh M.R., Ghasemi A., Harati H., Saadat N., and Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 8 (2008) 176
12. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 47 (2002) 408-426
13. Hadaegh F., Harati H., Ghanbarian A., and Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 571-577
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl. 1 (2003) S5-20
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
16. Tong P.C., Kong A.P., So W.Y., Yang X., Ho C.S., Ma R.C., et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 30 (2007) 1206-1211
17. Mak K.H., Ma S., Heng D., Tan C.E., Tai E.S., Topol E.J., et al. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am. J. Cardiol. 100 (2007) 227-233
18. Cull C.A., Jensen C.C., Retnakaran R., and Holman R.R. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation 116 (2007) 2119-2126
19. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304